「肝胆膵消化器病学」は横浜市立大学附属病院の消化器内科部門です


  1. A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma. Imajo K, Ogawa Y, Yoneda M, Saito S, Nakajima A. J Med Ultrason (2001). 2020 Jan 20. doi: 10.1007/s10396-019-00997-5. [Epub ahead of print] Review. PMID: 31960190
  2. Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Inadomi C, Takahashi H, Ogawa Y, Oeda S, Imajo K, Kubotsu Y, Tanaka K, Kessoku T, Okada M, Isoda H, Akiyama T, Fukushima H, Yoneda M, Anzai K, Aishima S, Nakajima A, Eguchi Y. Hepatol Res. 2020 Feb 23. doi: 10.1111/hepr.13495. [Epub ahead of print] PMID: 32090397
  3. Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver. Niikura T, Imajo K, Ozaki A, Kobayashi T, Iwaki M, Honda Y, Kessoku T, Ogawa Y, Yoneda M, Kirikoshi H, Saito S, Nakajima A. Diagnostics (Basel). 2020 Feb 26;10(3). pii: E129. doi: 10.3390/diagnostics10030129. PMID: 32111021
  4. Safety and efficacy of cold snare polypectomy for pedunculated (Ip) polyps measuring less than 10 mm in diameter. Arimoto J, Chiba H, Ashikari K, Fukui R, Tachikawa J, Suto T, Kawano N, Niikura T, Kuwabara H, Nakaoka M, Ida T, Higurashi T, Goto T, Nakajima A. Int J Colorectal Dis. 2020 May;35(5):859-867. doi: 10.1007/s00384-020-03547-5. Epub 2020 Feb 28. PMID: 32112197
  5. Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON. Int J Mol Sci. 2020 Mar 11;21(6). pii: E1907. doi: 10.3390/ijms21061907. Review. PMID: 32168769
  6. Clinical impact of evaluation of frailty in endoscopic submucosal dissection for early gastric cancer in elderly patients. Misawa N, Higurashi T, Tachikawa J, Tanabe H, Yoshihara T, Ashikari K, Kanoshima K, Fuyuki A, Ohkubo H, Saigusa Y, Chiba H, Nonaka T, Kuriyama H, Kobayashi N, Nakajima A. Geriatr Gerontol Int. 2020 Mar 16. doi: 10.1111/ggi.13905. [Epub ahead of print] PMID: 32175690
  7. Current and new pharmacotherapy options for non-alcoholic steatohepatitis. Sumida Y, Yoneda M, Ogawa Y, Yoneda M, Okanoue T, Nakajima A. Expert Opin Pharmacother. 2020 Apr 1:1-15. doi: 10.1080/14656566.2020.1744564. [Epub ahead of print] PMID: 32237916
  8. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. Pitisuttithum P, Chan WK, Piyachaturawat P, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VWS, Treeprasertsuk S. BMC Gastroenterol. 2020 Apr 6;20(1):88. doi: 10.1186/s12876-020-01240-z. PMID: 32252638
  9. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial. Kamata Y, Kessoku T, Shimizu T, Kobayashi T, Kurihashi T, Sato S, Kuraji S, Aoyama N, Iwasaki T, Takashiba S, Hamada N, Kodama T, Tamura T, Ino S, Higurashi T, Taguri M, Yamanaka T, Yoneda M, Usuda H, Wada K, Nakajima A, Minabe M. Trials. 2020 Mar 23;21(1):291. doi: 10.1186/s13063-020-4201-y. PMID: 32293522

↑ PAGE TOP